Both mutated signalling pathways are also found in tumours.33,35,36 Similarities in mutated genes between endothelial cells in tumour vessels and those in vascular malformations suggest a comparable phenotype and provide insights into the mechanisms of action of BEST in treating vascular malformations. This evidence concerns the gene BEST1 and vascular malformation.